Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2008 1
2010 2
2011 3
2012 5
2014 2
2015 4
2016 5
2017 7
2018 3
2019 6
2020 6
2021 8
2022 9
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.
Horesh ME, Martin-Fernandez M, Gruber C, Buta S, Le Voyer T, Puzenat E, Lesmana H, Wu Y, Richardson A, Stein D, Hodeib S, Youssef M, Kurowski JA, Feuille E, Pedroza LA, Fuleihan RL, Haseley A, Hovnanian A, Quartier P, Rosain J, Davis G, Mullan D, Stewart O, Patel R, Lee AE, Rubinstein R, Ewald L, Maheshwari N, Rahming V, Chinn IK, Lupski JR, Orange JS, Sancho-Shimizu V, Casanova JL, Abul-Husn NS, Itan Y, Milner JD, Bustamante J, Bogunovic D. Horesh ME, et al. Among authors: puzenat e. J Exp Med. 2024 Jun 3;221(6):e20232387. doi: 10.1084/jem.20232387. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563820
Low risk of embryonic and other cancers in PIK3CA-related overgrowth spectrum: Impact on screening recommendations.
Faivre L, Crépin JC, Réda M, Nambot S, Carmignac V, Abadie C, Mirault T, Faure-Conter C, Mazereeuw-Hautier J, Maza A, Puzenat E, Collonge-Rame MA, Bursztejn AC, Philippe C, Thauvin-Robinet C, Chevarin M, Abasq-Thomas C, Amiel J, Arpin S, Barbarot S, Baujat G, Bessis D, Bourrat E, Boute O, Chassaing N, Coubes C, Demeer B, Edery P, El Chehadeh S, Goldenberg A, Hadj-Rabia S, Haye D, Isidor B, Jacquemont ML, Van Kien PK, Lacombe D, Lehalle D, Lambert L, Martin L, Maruani A, Morice-Picard F, Petit F, Phan A, Pinson L, Rossi M, Touraine R, Vanlerberghe C, Vincent M, Vincent-Delorme C, Whalen S, Willems M, Marle N, Verkarre V, Devalland C, Devouassoux-Shisheboran M, Abad M, Rioux-Leclercq N, Bonniaud B, Duffourd Y, Martel J, Binquet C, Kuentz P, Vabres P. Faivre L, et al. Among authors: puzenat e. Clin Genet. 2023 Nov;104(5):554-563. doi: 10.1111/cge.14410. Epub 2023 Aug 14. Clin Genet. 2023. PMID: 37580112
Prurigo pigmentosa induced by a ketogenic diet.
Antoine L, Gallais Serezal I, Aubin F, Puzenat E. Antoine L, et al. Among authors: puzenat e. Eur J Dermatol. 2022 Jul 1;32(4):545-546. doi: 10.1684/ejd.2022.4313. Eur J Dermatol. 2022. PMID: 36301767 Free PMC article. No abstract available.
Gluten intolerance and skin diseases.
Humbert P, Pelletier F, Dreno B, Puzenat E, Aubin F. Humbert P, et al. Among authors: puzenat e. Eur J Dermatol. 2006 Jan-Feb;16(1):4-11. Eur J Dermatol. 2006. PMID: 16436335 Review.
Primary intestinal lymphangiectasia: A case report.
Antoine L, Chotard M, Koch S, Aubin F, Puzenat E. Antoine L, et al. Among authors: puzenat e. J Pediatr Gastroenterol Nutr. 2024 May;78(5):1197-1198. doi: 10.1002/jpn3.12093. Epub 2023 Dec 27. J Pediatr Gastroenterol Nutr. 2024. PMID: 38695601 No abstract available.
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Nardin C, Laheurte C, Puzenat E, Boullerot L, Ramseyer M, Marguier A, Jacquin M, Godet Y, Aubin F, Adotevi O. Nardin C, et al. Among authors: puzenat e. J Invest Dermatol. 2022 Feb;142(2):435-444. doi: 10.1016/j.jid.2021.07.160. Epub 2021 Aug 2. J Invest Dermatol. 2022. PMID: 34352265 Free article.
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Nardin C, Hennemann A, Diallo K, Funck-Brentano E, Puzenat E, Heidelberger V, Jeudy G, Samimi M, Lesage C, Boussemart L, Peuvrel L, Rouanet J, Brunet-Possenti F, Gerard E, Seris A, Jouary T, Saint-Jean M, Puyraveau M, Saiag P, Aubin F. Nardin C, et al. Among authors: puzenat e. Cancers (Basel). 2023 Jul 10;15(14):3564. doi: 10.3390/cancers15143564. Cancers (Basel). 2023. PMID: 37509227 Free PMC article.
Richner-Hanhart syndrome (tyrosinemia type II).
Locatelli F, Puzenat E, Arnoux JB, Blanc D, Aubin F. Locatelli F, et al. Among authors: puzenat e. Cutis. 2017 Dec;100(6):E20-E22. Cutis. 2017. PMID: 29360903 No abstract available.
[Adverse effects of immune checkpoint inhibitors used to treat melanoma and other cancer].
Jacquin-Porretaz C, Nardin C, Puzenat E, Roche-Kubler B, Aubin F; Comité de suivi des effets secondaires des immunothérapies anti-cancéreuses(CSESIAC). Jacquin-Porretaz C, et al. Among authors: puzenat e. Presse Med. 2017 Sep;46(9):808-817. doi: 10.1016/j.lpm.2017.05.032. Epub 2017 Jul 3. Presse Med. 2017. PMID: 28683958 Review. French.
61 results